Tirzepatide (Mounjaro and Zepbound) is a dual GLP-1/GIP receptor agonist approved by the FDA for managing blood sugar levels (Mounjaro) and chronic weight management (Zepbound)
Read More Key Benefits As a Dietary supplement for adults ,1 or 2 capsules daily preferably at mealtime or as directed by health practitioner
Retatrutide , a triple-action peptide (GIP/GLP-1/glucagon receptor agonist), is in late-stage clinical trials and has shown even more dramatic weight loss results than tirzepatide
Remember that improvements in blood sugar, blood pressure, body composition, and overall health may continue even if body weight temporarily remains the same
To remove any potential for spurious associations due to population stratification, we used a set of about 100,000 SNPs pruned for the LD structure and retrieved the first five principal component eigenvectors (PCs)